Search Results - "Ekong, Rosemary"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Checklist for gene/disease‐specific variation database curators to enable ethical data management by Ekong, Rosemary, Vihinen, Mauno

    Published in Human mutation (01-10-2019)
    “…Databases with variant and phenotype information are essential for advancing research and improving the health and welfare of individuals. These resources…”
    Get full text
    Journal Article
  8. 8

    Mild TSC phenotype and non-penetrance associated with a frameshift variant in TSC2 prompts caution in evaluating pathogenicity of frameshift variants by Farach, Laura S., Northrup, Hope, Nellist, Mark, van Unen, Leontine, Hillman, Paul, Klonowska, Katarzyna, Ekong, Rosemary, Crino, Peter B., Au, Kit Sing

    Published in Gene (15-08-2023)
    “…•Caution should be used when designating novel frameshift variants as pathogenic as predictions can be inaccurate and non-canonical splice sites may be created…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings by Dufner Almeida, Luiz G., Nanhoe, Santoesha, Zonta, Andrea, Hosseinzadeh, Mitra, Kom‐Gortat, Regina, Elfferich, Peter, Schaaf, Gerben, Kenter, Annegien, Kümmel, Daniel, Migone, Nicola, Povey, Sue, Ekong, Rosemary, Nellist, Mark

    Published in Human mutation (01-04-2020)
    “…The TSC1 and TSC2 gene products interact to form the tuberous sclerosis complex (TSC), an important negative regulator of the mechanistic target of rapamycin…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data? by Ingram, Catherine J. E., Ekong, Rosemary, Ansari-Pour, Naser, Bradman, Neil, Swallow, Dallas M.

    Published in The pharmacogenomics journal (01-02-2021)
    “…Inter-individual variation of drug metabolising enzymes (DMEs) leads to variable efficacy of many drugs and even adverse drug responses. Consequently, it would…”
    Get full text
    Journal Article
  16. 16

    Functional Assessment of TSC2 Variants Identified in Individuals with Tuberous Sclerosis Complex by Hoogeveen-Westerveld, Marianne, Ekong, Rosemary, Povey, Sue, Mayer, Karin, Lannoy, Nathalie, Elmslie, Frances, Bebin, Martina, Dies, Kira, Thompson, Catherine, Sparagana, Steven P., Davies, Peter, van den Ouweland, Ans, Halley, Dicky, Nellist, Mark

    Published in Human mutation (01-01-2013)
    “…ABSTRACT Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in the TSC1 or TSC2 genes. The TSC1 and TSC2 gene products,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Diversity of lactase persistence in African milk drinkers by Jones, Bryony Leigh, Oljira, Tamiru, Liebert, Anke, Zmarz, Pawel, Montalva, Nicolas, Tarekeyn, Ayele, Ekong, Rosemary, Thomas, Mark G., Bekele, Endashaw, Bradman, Neil, Swallow, Dallas M.

    Published in Human genetics (01-08-2015)
    “…The genetic trait of lactase persistence is attributable to allelic variants in an enhancer region upstream of the lactase gene, LCT . To date, five different…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4: an examination of the extent and potential implications by Creemer, Olivia J, Ansari-Pour, Naser, Ekong, Rosemary, Tarekegn, Ayele, Plaster, Christopher, Bains, Ripudaman K, Itan, Yuval, Bekele, Endashaw, Bradman, Neil

    Published in Pharmacogenetics and genomics (01-06-2016)
    “…CYP3A4 expression varies up to 100-fold among individuals, and, to date, genetic causes remain elusive. As a major drug-metabolizing enzyme, elucidation of…”
    Get full text
    Journal Article